Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :766
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed9384    
    Printed287    
    Emailed8    
    PDF Downloaded1017    
    Comments [Add]    
    Cited by others 15    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2007  |  Volume : 44  |  Issue : 2  |  Page : 51-55

Evaluation of adjunctive tests for cervical cancer screening in low resource settings


1 Department of Obstetrics and Gynaecology, AIIMS, New Delhi, India
2 Department of Biostatistics, AIIMS, New Delhi, India
3 Department of Epidemiology, Johns Hopkins Bloomberg, School of Public Health, USA
4 Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg, School of Public Health, USA
5 Department of Pathology, AIIMS, New Delhi, India

Correspondence Address:
Neerja Bhatla
Department of Obstetrics and Gynaecology, AIIMS, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-509X.35811

Rights and Permissions

Background: Visual inspection of cervix after application of acetic acid (VIA) is an effective screening tool for cervical cancer in low resource settings, but its low specificity leads to high referral rates. Adjunctive testing may overcome this drawback. Aims: This pilot study was aimed to assess test performances of VIA, human papillomavirus (HPV) testing and Pap smear, individually and in simulated combinations, to determine the probable best screening option. Setting and Design: Gynecology outpatient department (OPD); cross-sectional study. Materials and Methods: One hundred women with complaints of irregular vaginal bleeding or discharge, post coital bleeding or unhealthy cervix on examination underwent Pap smear, HPV testing, VIA, colposcopy and biopsy, if indicated, in this screening order. Statistical Analysis: Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated for each of the tests with a biopsy result of ≥HSIL taken as the gold standard. Simulated parallel and sequential combinations for VIA/Pap, VIA/HPV and HPV/Pap were calculated and compared with individual test performance. Results: Prevalence of abnormal Pap smears was 5%, VIA positive 51% and HPV positive 16%. Sensitivity and specificity of VIA were 100% and 53.3% respectively. For HPV and Pap tests corresponding figures were 85.7%, 89.7% and 50%, 98.9% respectively. The best simulated combination with a balance of sensitivity and specificity was of VIA followed by HPV testing (sensitivity 85.7%, specificity 95.4%). Conclusion: Addition of HPV testing to VIA can increase the specificity of VIA, thereby reducing the referral rates without compromising the sensitivity of the test.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow